358 completed, 25 recruiting, 24 unknown, 18 terminated. 143 Phase 3, 101 Phase 2, 68 Not applicable, 53 Phase 4, 31 Phase 1.
Follow Neisseriaceae Infections: new trials by email Literature Review of Neisseriaceae Infections trials Research Report on Neisseriaceae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans Integrated care - Opioid Use Disorder, HIV | Not applicable | Not yet recruiting | VA Office of Research and Development | 60 | 2028-04-03 | 2026-04-24 |
| Improving Clinic Delivery of HIV-related Anal Health Services PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea | Not applicable | Not yet recruiting | Albert Einstein College of Medicine | 8 | 2028-02-01 | 2026-10-13 |
| Optimizing Antibiotic Prescription in STI Clinics Using Rapid POCT cobas® Liat® CT/NG Point-of-Care Test - Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 404 | 2026-12-01 | 2026-10-20 |
| A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women Doxycycline hyclate, Standard of Care for STI prevention - Sexually Transmitted Infection (STI), Gonorrhea | Phase 3 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 580 | 2026-11-30 | 2026-10-20 |
| Outcomes From Point-of-Care Sexually Transmitted Infection (STI) Testing in an Urban Sexual Health Clinic: A Randomized Trial Point-of-care assay for chlamydia and gonorrhea, Laboratory-based chlamydia and gonorrhea NAAT, CRISPR-based assay - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection | Not applicable | Not yet recruiting | Massachusetts General Hospital | 400 | 2026-11-01 | 2026-10-06 |
| Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study Venue-based, peer-enhanced strategy for integrated HIV self-testing (and self-collected STI testing - HIV, Syphilis | Not applicable | Not yet recruiting | University of North Carolina, Chapel Hill | 232 | 2026-11-01 | 2026-10-29 |
| Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine in Junior High School Students Aged 13-15 Years MPSV-ACYW - Meningococcal Disease; Meningococcal Meningitis | Phase 4 | Not yet recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 200 | 2026-10-20 | 2026-10-21 |
| A Clinical Trial of the ACYW135 Group Meningococcal Polysaccharide-Conjugated Vaccine (CRM197 Vector) Previously vaccinated with MCV4 (CanSino), Previously vaccinated with MPSV4 (LvZhu) - Epidemic Meningitis | Not yet recruiting | CanSino Biologics Inc. | 180 | 2026-09-15 | 2026-08-03 | |
| Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml), Rectal swab for ESBL-E and microbiota (Eswab), Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) - Neisseria Gonorrhoeae (Ng) Infections | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 360 | 2026-09-01 | 2026-06-22 |
| Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur Inc., Swiftwater, PA, USA), Menhycia® (ACYW135 Meningococcal Conjugate Vaccine [CRM197]) (CanSino Biologics Inc., China) - Meningococcal Infection, Healthy Volunteers | Phase 3 | Recruiting | Sanofi | 4568 | 2026-08-22 | 2026-10-19 |
| Improving Maternal and Child Health Through Point-of-care STI Testing Point-of-care STI tests, Standard of care STI testing - Treponema Pallidum Infection, Chlamydia Trachomatis Infection | Not applicable | Recruiting | Emory University | 756 | 2026-08-11 | 2026-08-19 |
| National Rapid TLC: Testing and Linkage to Care Xpert® HIV-1 Qual XC - HIV, Chlamydia | Not applicable | Not yet recruiting | Unity Health Toronto | 2500 | 2026-08-01 | 2026-07-28 |
| Metagenomic Analysis of the Pharynx in High Risk Partners Gonorrhea, Neisseria Gonorrhea | Not yet recruiting | Guy's and St Thomas' NHS Foundation Trust | 100 | 2026-07-14 | 2026-06-30 | |
| 500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection ceftriaxone 500-mg, ceftriaxone 1000-mg - Gonorrhea Infection | Phase 3 | Recruiting | National Taiwan University Hospital | 400 | 2026-07-01 | 2026-07-17 |
| Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland HIV (Human Immunodeficiency Virus), Chlamydia | Not yet recruiting | University of Zurich | 1800 | 2026-04-07 | 2026-04-08 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 880 | 2026-03-25 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 1040 | 2026-03-22 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 1040 | 2026-03-22 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years experimental vaccine, active comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Active not recruiting | Sinovac Biotech Co., Ltd | 660 | 2026-03-22 | 2026-08-10 |
| Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Doxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling - Gonorrhea, Chlamydia | Phase 4 | Recruiting | Westat | 760 | 2026-02-27 | 2026-10-16 |
Showing 20 of 454. Sign in to see all of them.
Meningococcal Infections (229) · Gonorrhea (158) · Meningitis, Meningococcal (125) · Meningitis (92) · Chlamydia Infections (90) · Sexually Transmitted Diseases (55) · Syphilis (31) · HIV Infections (21) · Acquired Immunodeficiency Syndrome (17) · Trichomonas Infections (17) · Tetanus (12) · Whooping Cough (12) · Diphtheria (10) · Haemophilus Infections (9) · Hepatitis B (7)
Bacterial Infections and Mycoses (454) · Gram-Negative Bacterial Infections (452) · Bacterial Infections (450) · Infections (448) · Neuroinflammatory Diseases (171) · Nervous System Diseases (169) · Communicable Diseases (166) · Urogenital Diseases (166) · Genital Diseases (164) · Sexually Transmitted Diseases, Bacterial (158) · Central Nervous System Diseases (127) · Central Nervous System Bacterial Infections (126) · Central Nervous System Infections (125) · Meningitis, Bacterial (125)
Meningococcal Vaccines (74) · 4CMenB vaccine (35) · MenACWY-CRM vaccine (16) · Ceftriaxone (15) · Vaccines (15) · Heptavalent Pneumococcal Conjugate Vaccine (14) · Tetanus Toxoid (13) · Azithromycin (11) · 13-valent pneumococcal vaccine (10) · Measles-Mumps-Rubella Vaccine (10) · Hepatitis B Vaccines (9) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (9) · Doxycycline (8) · Blood Specimen Collection (7) · Ciprofloxacin (7)
GlaxoSmithKline (75) · Sanofi Pasteur, a Sanofi Company (56) · Novartis Vaccines (51) · National Institute of Allergy and Infectious Diseases (NIAID) (17) · Pfizer (15) · CanSino Biologics Inc. (8) · Novartis (8) · University of Washington (8) · Northwestern University (5) · Public Health England (5) · Sanofi (5) · University of California, San Francisco (5) · University of Oxford (5) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (4) · Sinovac Biotech Co., Ltd (4)
United States (181) · United Kingdom (35) · Germany (28) · China (25) · Australia (24) · Finland (22) · Spain (18) · Czechia (17) · France (17) · Canada (16) · Italy (15) · Poland (14) · Puerto Rico (13) · South Korea (12) · Philippines (11)
Elizabeth Coates, PhD (3) · Jim Carey, MPH (3) · Julius Schachter, PhD (3) · Alberto Yataco, MD (2) · Brian Mustanski, PhD (2) · Chris Kenyon, MD (2) · Helen Marshall (2)
PMID 35164991, PMID 31110098, PMID 35257644, PMID 33020485, PMID 17287313, PMID 17301105, PMID 21099596, PMID 21177912, PMID 23324563, PMID 29253560, PMID 29550195, PMID 30061029, PMID 33325757, PMID 35710444, PMID 36369456, PMID 37018493, PMID 37351709, PMID 38118022, PMID 10582782, PMID 11386956, PMID 11880389, PMID 12392124, PMID 12593898, PMID 12904390, PMID 12958275, PMID 15937765, PMID 16203934, PMID 16314767, PMID 16314768, PMID 16417952, PMID 16455891, PMID 16567982, PMID 16825373, PMID 17051493, PMID 17065257, PMID 17072120, PMID 17077230, PMID 17548138, PMID 1777459, PMID 18038280, PMID 18532873, PMID 19023429, PMID 19048025, PMID 19091990, PMID 19104366, PMID 19220138, PMID 19321868, PMID 19389002, PMID 19476428, PMID 19549331
2017 (9), 2016 (7), 2014 (6), 2019 (6), 2008 (4), 2009 (4), 2018 (3), 1IK2CX002822-01A1 (1), 2005 (1), 2023 (1), 2025 (1), 5UM1AI104681 (1), 5UM1AI106707 (1), 5UM1AI148576-05 (1), D43TW009340 (1)